Cardiovascular Disease

Active Projects: 32

Project Investigator All Topics Start date End date
The Selective Marketing of Sugar-Sweetened Beverages (SSBs) to Children: An Analysis of Internal Industry Documents Laura A. Schmidt, PhD Cardiovascular Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Pediatrics
Social and Cultural Influences on cardiovascular risk factors in South Asians Alka M. Kanaya, MD Cardiovascular Disease
St Jude Medical - 2015 Electrophysiology Fellowship 20150226 Nitish Badhwar, MD Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training
Endothelial Primary Cilia Protect Against Atherosclerosis Jeremy F. Reiter, MD, PhD Cardiovascular Disease
ZERO AF Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Nitish Badhwar, MD Cardiovascular Disease
Prospective, Comparative, Randomized, Multi-Center, Double-Blinded, Placebo- Controlled, Phase 2a Study of the Safety and Efficacy of CMX-2043 for Periprocedural Injury Protection in Subjects Undergoing Coronary Angiography at Risk of Rad Yerem Yeghiazarians, MD Cardiovascular Disease
Data Fusion-A Self-Scaling, Open Source Registry Advancing Pediatric Pulmonary Vascular Disease Research Jeffrey R. Fineman, MD Cardiovascular Disease, Pediatrics
Ectopic Fat and Atherosclerosis in South Asians Alka M. Kanaya, MD Noncommunicable and/or Chronic Disease, Cardiovascular Disease
Ectopic fat and atherosclerosis in South Asians Alka M. Kanaya, MD Cardiovascular Disease
Controlled Thirdhand Smoke Exposure Core Suzaynn F. Schick, PhD Cardiovascular Disease, Chronic Respiratory Disease, Occupational and Environmental Disease
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging
Prime: Signaling and Transcriptional Networks in Cardiac Patterning; Project 3 (UCSF, Black, BL): Regulation of cardiac gene expression by MEF2-Myocardin transcriptional complexes Cardiovascular Disease
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD HIV/AIDS, Cardiovascular Disease, Chronic Respiratory Disease, Aging
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Mediators of Atherosclerosis in South Asians Living in America Alka M. Kanaya, MD Cardiovascular Disease, Immigration and Migration
Lifecourse Cardiovascular Risk, Depression and Cognition in Black & White Adults Eric Vittinghoff, PhD Cardiovascular Disease
Measuring Relative Cardiovascular Health Risks of Inhaled Tobacco Products Matthew Springer, PhD Cardiovascular Disease, Smoking and Tobacco
Antibody Repertoire Diversity in CVD, Aging, Death in a Large Multi-Ethnic Cohort Shaun R. Coughlin, MD, PhD Cardiovascular Disease, Aging
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Norah A. Terrault, MD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
The Impact of Cardiac Care Regionalization on Access, Treatment, and Outcomes Renee Y. Hsia, MD Cardiovascular Disease
Randomized, Double-Blind Placebo-Controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects with Stable Atherosclerotic Cardiovascular Disease Using FDG PET/CT Imaging Priscilla Y. Hsue, MD Cardiovascular Disease
International Clinical Research Fellowship Christopher C. Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
ENSURE in AF: Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Parallel Group Study Comparing Edoxaban with Enoxaparin/Warfarin Followed by Warfarin Alone in Subjects Undergoing Planned electrical cardioversion of nonvalvular atrial fibrillat Nitish Badhwar, MD Cardiovascular Disease
Guideline development for rheumatic heart disease and endocarditis Ann Bolger, MD Cardiovascular Disease, Systematic Reviews and Guideline Development
Mindfulness-education intervention for atrial fibrillation symptom management Linda Ottoboni, RN, MS Cardiovascular Disease, Patient and Peer Education
Epidemiology of stroke Anthony S. Kim, MD Cardiovascular Disease, Neurology and Mental Health, Dementia and Cognitive Impairment
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD HIV/AIDS, Cardiovascular Disease, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Substance Abuse, Training and Capacity Building
Optimization of health care expenditures to maximize societal value Dhruv Kazi, MD, MSc, MS Cardiovascular Disease, Drug and Diagnostics Development, Health Economics and Policy
Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System compared to the HeartMate II® VAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation Georg M. Wieselthaler, MD Cardiovascular Disease, Pharmacology and Drug Treatment
Actelion - AC-065A304 Multicenter, open-label, single-group study to assess the tolerability and the safety of the TRANSITion from inhaled tresprostinil to oral selexipag in patients with pulmonary arterial hypertension 20150803 Cardiovascular Disease, Pharmacology and Drug Treatment
A Phase 1 Study to Evaluate the Effect of NKTR-102 for Injection (etirinotecan pegol) on the QT/QTc Interval in Patients With Advanced or Metastatic Solid Tumors Pamela N. Munster, MD Cardiovascular Disease
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) Cardiovascular Disease

Active Projects: 122

Project Investigator All Topics Start date End date
Mechanisms of Pulmonary Ischemia-Reperfusion Injury Cardiovascular Disease
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS Eric Vittinghoff, PhD Cardiovascular Disease, Women's Health
California Acute Stroke Prototype Registry (CASPR) / Development of Prototypes for the Paul Coverdell National Acute Stroke Registry Cardiovascular Disease
Estrogen Receptor Variance and CHD Risk in HERS Eric Vittinghoff, PhD Cardiovascular Disease
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Study Cardiovascular Disease
Resynchronization Hemodynamic Treatment for Heart Failure Management Study (Rythm ICD) Nitish Badhwar, MD Cardiovascular Disease
Failure Time Methods for Family Disease Studies David V. Glidden, PhD Cardiovascular Disease
Novel Biomarkers of Perioperative Cardiovascular Risk Cardiovascular Disease
Molecular Mechanism of Post-myocardial Infarction Cardiac Regeneration by Novel Therapeutic Peptides Matthew Springer, PhD Cardiovascular Disease
Optimizing Management of Transient Ischemic Attacks Cardiovascular Disease, Pharmacology and Drug Treatment
CASTIA Neurological Core Imaging Lab (NCIL) Cardiovascular Disease, Pharmacology and Drug Treatment, Neurology and Mental Health
Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack in U.S. Community Hospitals Cardiovascular Disease, Pharmacology and Drug Treatment
Closed-Chest Cell Injections into Mouse Mycardium Targeted by Ultrasound Matthew Springer, PhD Cardiovascular Disease
Quality Improvement in Stroke Prevention (QUISP) Cardiovascular Disease, Neurology and Mental Health
Pharmacokinetics and Pharmacodynamics of Nicotine Neal L. Benowitz, MD Cardiovascular Disease, Smoking and Tobacco
Impact of Flavanols on Vascular Reactivity and Cardiac Function in Rodents Measured with High Resolution Ultrasound Matthew Springer, PhD Cardiovascular Disease
Safety of Sports for Patients with Implantable Cardioverter-Defibrillators: A Multicenter Registrry Nitish Badhwar, MD Cardiovascular Disease
Metabolic Syndrome and Atherosclerosis in South Asians Alka M. Kanaya, MD Cardiovascular Disease, Diabetes
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System (CF-EAS) for the Treatment of Symptomatic Atrial Fibrillation (ENABLE-AF) Nitish Badhwar, MD Cardiovascular Disease
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
NSA Guidelines Cardiovascular Disease, Systematic Reviews and Guideline Development
Pacemarker & Beta-Blocker Therapy Post-Myocardial Infarct Nitish Badhwar, MD Cardiovascular Disease
Endothelial progenitor cells and surgical outcomes Cardiovascular Disease
Variations in Care: Developing Interventions to Reduce Variation in Heart Failure Care Cardiovascular Disease
Replace Registry Nitish Badhwar, MD Cardiovascular Disease
Body Surfacing Mapping to Guide Resynchronization Therapy for Congestive Heart Failure Nitish Badhwar, MD Cardiovascular Disease
Endothelial Function and Glucose Tolerance in South Asians Alka M. Kanaya, MD Cardiovascular Disease, Diet, Exercise, and Obesity
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program Ruth M. Greenblatt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education
Improving use of peri-operative beta-blockers with a multidimensional QI program Cardiovascular Disease
MAPS: Matrix And Platinum Science, A Prospective, Randomized, Multicenter, Trial Investigating Matrix2 tm and GDC? Coils for the treatment of intracranial saccular aneurysms Trial Cardiovascular Disease, Pharmacology and Drug Treatment
Adapting of the Coronary Heart Disease Policy Model to U.S. Subpopulations Kirsten Bibbins-Domingo, MD, PhD Cardiovascular Disease
Bone Marrow Cell Therapy for Cardiac Disease: Impact of Donor Age and Infarction Matthew Springer, PhD Cardiovascular Disease
Therapeutic Effects of Pharmacological Manipulation of Intracellular Nitric Oxide Levels in Cardiovascular Disease Matthew Springer, PhD Cardiovascular Disease, Pharmacology and Drug Treatment
NAAccord (CHK-UP on HIV Supplement) Jeffrey N. Martin, MD, MPH HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
Neuroform Angiographic Analysis (Subset of MAPS study data) Cardiovascular Disease, Drug and Diagnostics Development
Developmental Regulation of Semilunar Valve and Ventricular Septum Formation Cardiovascular Disease
Development of Human mAbs to Target Cardiomyocytes and Cardiac Fibroblasts Cardiovascular Disease, Immunology
A Randomized Trial of Unruptured Brain Arteriovenous Malformation (ARUBA) William L. Young, MD Cardiovascular Disease
Perceived Discrimination, Stress Responses and Cardiovascular Regeneration among African Americans Kirstin E. Aschbacher, PhD Cardiovascular Disease, Stigma and Discrimination
Angiogenesis in Moving Cardiac Tissue: Influence of Motion on Endothelial Pattern Formation and Gene Expression Matthew Springer, PhD Cardiovascular Disease
Microrna Regulation of Cardiac Cell Polarity in Development and Disease Cardiovascular Disease
Stimulants and Childhood Stroke: a Population-Based Nested Case-Control Study Nancy K. Hills, PhD Cardiovascular Disease, Pediatrics
Evaluation of BD Vacutainer SST Ultra and Serum Ultra Blood Collection Tubes for Selected Therapeutic Drugs (Sample Collection) Alan H. Wu, PhD Cardiovascular Disease, Drug and Diagnostics Development
Outcomes Modeling for VA Return on Investment Analysis Kirsten Bibbins-Domingo, MD, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Diet, Exercise, and Obesity, Health Economics and Policy
Enhancing Mexican Capacity for Cardiovascular Policy Research Kirsten Bibbins-Domingo, MD, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Health Economics and Policy
Restorative Yoga for Therapy of the Metabolic Syndrome (RHYTHMS) Study Alka M. Kanaya, MD Cardiovascular Disease, Diabetes, Diet, Exercise, and Obesity
Cardiac Regeneration Through Growth Factor Eluting Microrod Scaffolds Tejal A. Desai, PhD Cardiovascular Disease
Evaluation of Harmful Effects of Cannabis Smoke on Vascular Endothelial Function Matthew Springer, PhD Cardiovascular Disease, Occupational and Environmental Disease, Smoking and Tobacco
Epi4K: Gene discovery in 4,000 Epilepsy Genomes (4/7) Elliott H. Sherr, MD, PhD Cardiovascular Disease, Genetics
Protein Inhibitor of Galectin-3 to Limit Fibrosis after Myocardial Infarction Matthew Springer, PhD Cardiovascular Disease
The cardiovascular impact of household air pollution in semi-urban and rural communities in Puno, Peru Melissa Burroughs Pena, MD, MS Cardiovascular Disease, Occupational and Environmental Disease
Myocardial Reconstruction for the Treatment of CHF Cardiovascular Disease
Teleconsultation by Emergency Medical Services For Acute Stroke Recognition: Feasibility Study Cardiovascular Disease
Myocardial Reconstruction for the Treatment of Congestive Heart Failure (CHF) Cardiovascular Disease
A Self-Care Intervention for Hispanic Patients with Heart Failure Cardiovascular Disease
On-Call Interventional Cardiology Physicians Services Jeffrey E. Olgin, MD Cardiovascular Disease
Impact of Regionalization of Care in Acute Stroke Patients Cardiovascular Disease
Proof of Concept of a Novel Transcatheter Aortic Valve Elaine E. Tseng, MD Cardiovascular Disease, Drug and Diagnostics Development
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals Hiroyu Hatano, MD, MHS HIV/AIDS, Cardiovascular Disease
Transcriptional Control of Endothelial Cell Specification and Sub-specification Cardiovascular Disease
St. Jude EP Fellowship Program Nitish Badhwar, MD Cardiovascular Disease
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Tanya C. Warwick, MD Cardiovascular Disease, Neurology and Mental Health
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Insulin Resistance Intervention after Stroke (IRIS) Trial Tanya C. Warwick, MD Cardiovascular Disease, Diabetes
UC Collaborative to Reduce Hospital Acquired Venous thromboembolism(HA VTE); Stop the Clot Cardiovascular Disease
Phase I/II-A Multicenter, Controlled, Randomized. Open-Label, Dose-Escalation, Safety, Tolerability, and Pharmacokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage. Cardiovascular Disease
Regulation of cardiovascular transcription Cardiovascular Disease, Newborn and Infant Health
Improving management of cardiovascular medications during hospitalization Cardiovascular Disease, Risk Reduction and Prevention, Training and Capacity Building, Training International Scholars and Clinicians, UCSF Professional Education
Phase III Clinical Trial "Platelet Oriented Inhibition in New Tia" - Drug: Plavix Cardiovascular Disease, Pharmacology and Drug Treatment
Development of a Pre-ß-1 HDL Diagnostic Assay John P. Kane, MD, PhD Cardiovascular Disease, Drug and Diagnostics Development
FHS HeH Pilot study Jeffrey E. Olgin, MD Cardiovascular Disease
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease Caryn L. Bern, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease
Structural Studies of Ion Channel Assembly and Signaling Complexes Daniel Minor, JR, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease
Everest II Endovascular Valve Edge to Edge Repair Study Lab Elyse Foster, MD Surgery and Anesthesia, Cardiovascular Disease
Enhancing Mexican Capacity for CVD Policy Research Alicia Fernandez, MD Cardiovascular Disease
Enhancing Mexican Capacity for Cardiovascular Disease (CVD) Policy Research Kirsten Bibbins-Domingo, MD, PhD Cardiovascular Disease, Training and Capacity Building
Genetic and Chemical Biological Studies of K2P Structure, Function, and Modulation Daniel Minor, JR, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Pharmacology and Drug Treatment, Neurology and Mental Health, Risk Reduction and Prevention
Detection of Cholesteryl Ester Storage Disease (CESD) Patients John P. Kane, MD, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease
An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (PRADAXA) Nitish Badhwar, MD Cardiovascular Disease
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane V. Havlir, MD HIV/AIDS, Cardiovascular Disease
Association of Occupational Noise Exposure with Cardiovascular Diseases among Career Firefighters Dal L. Chin, PhD Cardiovascular Disease, Occupational and Environmental Disease
Preventing Morbidity and Mortality and Heart Failure Among Persons with Chronic Renal Insufficiency Michael G. Shlipak, MD Noncommunicable and/or Chronic Disease, Cardiovascular Disease
Molecular genetics of cardiac cell differentiation Shaun R. Coughlin, MD, PhD Cardiovascular Disease
SOCRATES - Acute Stroke Or Transient Ischaemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes Cardiovascular Disease, Pharmacology and Drug Treatment
Cumulative Stress and CVD Risk in Middle-Aged And Older Women Michelle A. Albert, MD, MPH Cardiovascular Disease, Women's Health
Hypertension Treatment Adherence in a Low-Income Tribal Region of Rural Southern India. A Qualitative Study Kaylan Agnew, MS Cardiovascular Disease
A Randomized, Double Blind Placebo-controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects with Stable Atherosc Yerem Yeghiazarians, MD Cardiovascular Disease
Image-Based Numerical Predictions of Hemodynamics following Vascular Intervention David A. Saloner, PhD Cardiovascular Disease, Drug and Diagnostics Development, Neurology and Mental Health
VIPS: Vascular Effects of Infection in Pediatric Stroke Heather J. Fullerton, MD Cardiovascular Disease, Neurology and Mental Health, Pediatrics
The distribution and determinants of Non-communicable Diseases in informal settlements (slums) in Northeastern Brazil Alon Unger, MD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Occupational and Environmental Disease
The Health ePeople Resource for Mobilized Research Jeffrey E. Olgin, MD Cardiovascular Disease
Stroke Hyperglycemia Insulin Network Effort (Shine) Trial Study; Task Order 6 J. Claude Hemphill, MD Cardiovascular Disease
UCSF Abundant Life Health Ministry Initiative Rena J. Pasick, DrPH Cancer/Oncology, Cardiovascular Disease, Diabetes, Patient and Peer Education
The Impact of Cardiac Care Regionalization on Access, Treatment, and Outcomes Renee Y. Hsia, MD Cardiovascular Disease, Access or Barriers to Care
DIADS Project 2: Racial Disparities in Ischemic Stroke and Atherosclerotic Risk Factors in the Young Heather J. Fullerton, MD Cardiovascular Disease, Neurology and Mental Health
Acute Cardiopulmonary Effects of Controlled Exposure to Wood Smoke Suzaynn F. Schick, PhD Cardiovascular Disease, Chronic Respiratory Disease, Occupational and Environmental Disease
In vivo diagnostics for cardiovascular disease Charles S. Craik, PhD Cardiovascular Disease
Cardiac Pacemaker Development Takashi Mikawa, PhD Cardiovascular Disease
Genomics of blood pressure-induced target organ damage Neil J. Risch, PhD Cardiovascular Disease
Medtronic - 2015 EP Fellowship 20141212 RB Nitish Badhwar, MD Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training
Overcoming impairment of bone marrow cell therapy for myocardial infarction: Role of B cells Matthew Springer, PhD Cardiovascular Disease
Predicting Stroke after Trauma (PSAT) Heather J. Fullerton, MD Cardiovascular Disease
Effect of low dose methotrexate on endothelial function and inflammation in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Genetic and molecular pathophysiology of ATS Louis J. Ptacek, MD Cardiovascular Disease, Genetics
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus Kirsten Bibbins-Domingo, MD, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Diabetes, Diet, Exercise, and Obesity
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane V. Havlir, MD HIV/AIDS, Cardiovascular Disease
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus Kirsten Bibbins-Domingo, MD, PhD Cardiovascular Disease, Diabetes
Perinatal Pulmonary Hypertension: Developmental Mediators Jeffrey R. Fineman, MD Cardiovascular Disease, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
Effect of low dose methotrexate on endothelial function and inflammation in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Effects of Psychosocial Stress on Endothelial Progenitor Cells Kirstin E. Aschbacher, PhD Cardiovascular Disease
Childhood SES Factors: Impact on age-related cognitive and vascular health Maria Glymour, ScD, MS Cardiovascular Disease
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Developing and Implementing a Heart Healthy Integrative Diet for Chinese American Patients Jane Jih, MD, MPH Cardiovascular Disease, Diet, Exercise, and Obesity
Evaluating Perceptions of Cardiovascular Disease Risk and Prevention: A Qualitative Study in an UnderResourced Setting in Rural South India Joan Chang, MS Cardiovascular Disease
Role of Monocyte Oxidative Stress and Mineralocorticoid Receptor Signaling on Cardiovascular Disease and Persistent Inflammation in Antiretroviral-Treated HIV+ Persons Jeffrey Milush, PhD HIV/AIDS, Cardiovascular Disease
Relationships between Alcohol, Patient Characteristics, and Atrial Fibrillation Isaac R. Whitman, MD Cardiovascular Disease, Substance Abuse
Molecular and Cellular Basis of Cardiovascular Disease Shaun R. Coughlin, MD, PhD Cardiovascular Disease
UCSF-GIVI Center for AIDS Research (CFAR) Paul A. Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
Futility Study of Deferoxamine in Intracerebral Hemorrhage "DIMINIsH" Vineeta Singh, MD Cardiovascular Disease, Pharmacology and Drug Treatment
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane V. Havlir, MD HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension Vijay P. Balasubramanian, MD, MRCP Cardiovascular Disease, Chronic Respiratory Disease